T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.42B |
| 2 |
Wynn Resorts
WYNN
|
+$992M |
| 3 |
Eli Lilly
LLY
|
+$964M |
| 4 |
Visa
V
|
+$700M |
| 5 |
American Airlines Group
AAL
|
+$626M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$1.24B |
| 2 |
Dollar Tree
DLTR
|
+$1.13B |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.03B |
| 4 |
Gilead Sciences
GILD
|
+$792M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$788M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.45% |
| 2 | Consumer Discretionary | 13.78% |
| 3 | Financials | 12.98% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Ventas
VTR
$45.7B
| $29.9M | 0.01% |
422,532
+2,364
| +0.6% | +$173K |
|
|
KND
1002
DELISTED
Kindred Healthcare
KND
| $29.9M | 0.01% |
1,539,280
-488,400
| -24% | -$10.6M |
|
|
CBK
1003
DELISTED
Christopher & Banks Corporation
CBK
| $29.7M | 0.01% |
2,998,537
-447,060
| -13% | -$4.29M |
|
|
MNTA
1004
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $29.6M | 0.01% |
2,606,412
-11,900
| -0.5% | -$136K |
|
1005
Paychex
PAYX
$42.8B
| $29.4M | 0.01% |
665,306
+5,000
| +0.8% | +$210K |
|
|
INFA
1006
DELISTED
INFORMATICA CORP
INFA
| $29.4M | 0.01% |
858,694
-319,950
| -27% | -$10.6M |
|
1007
PVH
PVH
$3.76B
| $29.4M | 0.01% |
242,438
-299,425
| -55% | -$35.1M |
|
1008
Mueller Water Products
MWA
$4.09B
| $29.4M | 0.01% |
3,546,437
+135,060
| +4% | +$1.17M |
|
1009
Edwards Lifesciences
EW
$53.6B
| $29.2M | 0.01% |
1,713,150
+10,200
| +0.6% | +$161K |
|
1010
AptarGroup
ATR
$8.43B
| $29M | 0.01% |
478,160
-21,200
| -4% | -$1.35M |
|
1011
American Vanguard Corp
AVD
$64M
| $29M | 0.01% |
2,591,326
+64,644
| +3% | +$832K |
|
|
UBA
1012
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $29M | 0.01% |
1,428,580
+246,321
| +21% | +$5.15M |
|
1013
Modine Manufacturing
MOD
$10.6B
| $28.9M | 0.01% |
2,430,550
-44,400
| -2% | -$620K |
|
|
GTS
1014
DELISTED
Triple-S Management Corporation
GTS
| $28.7M | 0.01% |
1,516,095
-16,292
| -1% | -$286K |
|
1015
Exelixis
EXEL
$12.5B
| $28.7M | 0.01% |
18,741,050
-554,290
| -3% | -$1.78M |
|
1016
Forestar Group
FOR
$1.49B
| $28.6M | 0.01% |
1,616,072
+1,107,632
| +218% | +$21.2M |
|
1017
Zimmer Biomet
ZBH
$18.7B
| $28.6M | 0.01% |
293,165
+1,236
| +0.4% | +$122K |
|
1018
Preferred Bank
PFBC
$1.26B
| $28.5M | 0.01% |
1,264,293
+118,940
| +10% | +$2.77M |
|
|
FRED
1019
DELISTED
Fred's Inc
FRED
| $28.4M | 0.01% |
2,029,904
+383,990
| +23% | +$5.88M |
|
|
SAVE
1020
DELISTED
Spirit Airlines, Inc.
SAVE
| $28.1M | 0.01% |
405,720
-12,600
| -3% | -$863K |
|
1021
Viatris
VTRS
$18.5B
| $28M | 0.01% |
615,970
+23,490
| +4% | +$1.14M |
|
1022
iShares MSCI Taiwan ETF
EWT
$11.6B
| $28M | 0.01% |
915,300
+197,800
| +28% | +$6.36M |
|
1023
Parker-Hannifin
PH
$135B
| $27.9M | 0.01% |
244,375
+1,900
| +0.8% | +$224K |
|
|
PHX
1024
DELISTED
PHX Minerals
PHX
| $27.9M | 0.01% |
934,170
+2,000
| +0.2% | +$61.5K |
|
1025
Affiliated Managers Group
AMG
$9.57B
| $27.9M | 0.01% |
139,089
+1,800
| +1% | +$367K |
|
Similar funds
T. Rowe Price Associates's Q3 2014 Portfolio in Review
As of Q3 2014, T. Rowe Price Associates held 2,614 positions worth $458B, down 1% from $463B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q3 2014 filing shows 88 new, 949 increased, 837 reduced and 73 closed positions. Its largest new stake was Alibaba: 26,922,443 shares worth $2.39B. The largest sale was PepsiCo, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2014 buy was Alibaba: 26,922,443 shares worth $2.39B.
- T. Rowe Price Associates added most to Wynn Resorts in Q3 2014, an estimated $992M increase.
- T. Rowe Price Associates's biggest Q3 2014 reduction was PepsiCo, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited ROCKWOOD HLDGS INC in Q3 2014, selling an estimated $788M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $458B portfolio in Q3 2014.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2014.
- T. Rowe Price Associates's portfolio value fell 1% quarter-over-quarter to $458B.
Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.